biomarker_id	biomarker	assessed_biomarker_entity	assessed_biomarker_entity_id	assessed_entity_type	condition	condition_id	exposure_agent	exposure_agent_id	best_biomarker_role	specimen	specimen_id	loinc_code	evidence_source	evidence	tag
A0001	entry 1 increased IL6 level	entry 1 Interleukin-6	entry 1 UPKB:p05231	entry 1 protein	entry 1 prostate cancer	entry 1 DOID:10283			prognostic	entry 1 blood	entry 1 UBERON:0000178	entry 1 26881-3	entry 1 PubMed:entry 1 10914713	entry 1 In multivariate analysis, however, the only two significant prognostic factors were EOD and IL-6. These results indicate that the serum IL-6 level is a significant prognostic factor for prostate cancer as well as EOD.	biomarker
A0002	entry 2 increased IL6 level	entry 2 Interleukin-6	entry 2 UPKB:p05231	entry 2 protein	entry 2 prostate cancer	entry 2 DOID:10283			predictive	entry 2 blood	entry 2 UBERON:0000178	entry 2 26881-3	entry 2 PubMed:entry 2 10914713	entry 2 In multivariate analysis, however, the only two significant prognostic factors were EOD and IL-6. These results indicate that the serum IL-6 level is a significant prognostic factor for prostate cancer as well as EOD.	biomarker
